Pfizer and Allergan merger to create uncertainty for agencies, execs say
The deal has also been criticized as a tax dodge as it will allow New York-based Pfizer to move its headquarters abroad.
To continue reading this article you need to be registered with Campaign. Registration is free and only takes a minute. Register here or sign in below if you already have an account.